TSE:6849Medical Equipment
Nihon Kohden (TSE:6849): Valuation Check as New FDA-Cleared EEG Devices Debut at AES 2025
Nihon Kohden (TSE:6849) is stepping into the American Epilepsy Society 2025 meeting with fresh, FDA cleared EEG gear that tightens its neurological care story and gives investors a clearer view of future demand.
See our latest analysis for Nihon Kohden.
Despite this uptick in clinical visibility, the stock has had a choppy run, with a weak year to date share price return but a positive three year total shareholder return suggesting the longer term story is still intact.
If Nihon Kohden's move...